Xicai Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xicai Sun has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Dehui Wang
Department of Otolaryngology-Head and Neck Surgery, Eye & ENT Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China
27 shared publications Huan Wang
High Altitude Rhinology Research Center Eye & ENT Hospital of Fudan University and People's Hospital of Shigatse City Shanghai China
26 shared publicationsLi Hu
Eye & ENT Hospital of Fudan University Shanghai China
24 shared publicationsWanpeng Li
ENT Institute and Department of Otorhinolaryngology, Head and Neck Surgery Fudan University Eye Ear Nose and Throat Hospital Shanghai China
21 shared publications- Hongmeng Yu
Department of Otolaryngology, Research Units of New Technologies of Endoscopic Surgery in Skull Base Tumor (2018RU003), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
19 shared publications Quan Liu
ENT Institute and Department of Otolaryngology, Eye & ENT Hospital Fudan University Shanghai China
17 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 12 (5) , 576-585
Multi‐Sequence Fusion MRI Deep Learning Models for Discrimination of Recurrent Nasopharyngeal Carcinoma and Osteoradionecrosis
Objectives: To develop a multi‐sequence fusion model based on MRI images to differentiate between recurrent nasopharyngeal carcinoma (rNPC) and osteoradionecrosis (ORN) in patients with nasopharyngeal carcinoma (NPC) after radiotherapy, and to evaluate its diagnostic performance. Methods: We retrospectively reviewed 370 patients with pathologically confirmed recurrent nasopharyngeal carcinoma (rNPC) or osteoradionecrosis (ORN). After screening, 346 patients (207 rNPC and 139 ORN) with both axial T1‐weighted contrast‐enhanced imaging (T1C) and T2‐weighted imaging (T2WI) were included and randomly split into a training set ( n = 212), validation set ( n = 61), and test set ( n = 73). A dual‐branch 3D‐ResNet‐50‐based fusion model was developed to integrate multi‐sequence MRI features. Model performance was evaluated using AUC, accuracy, sensitivity, specificity, precision, and F1 score. Results: On the test set, the proposed 3D‐ResNet‐Fusion model achieved an AUC of 0.86 and an accuracy of 84%, with a sensitivity of 91%, specificity of 72%, precision of 83%, and an F1 score of 0.87. Based on AUC comparisons, the fusion model outperformed comparator models based on EfficientNet (0.77, p = 0.20) and DenseNet (0.70, p = 0.02), as well as single‐sequence 3D‐ResNet models trained on T1C alone (0.71, p = 0.02) or T2WI alone (0.73, p = 0.046). In the human–AI comparison experiment, the proposed AI model achieved a 3% higher ACC than the senior otolaryngologist ( p = 0.83), and outperformed the two junior otolaryngologists by 15% ( p = 0.05) and 22% ( p < 0.01), respectively. Conclusion: The proposed AI model effectively integrates information from multiple MRI sequences, significantly improving classification performance in distinguishing rNPC from ORN.
- 7 September 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 12 (5) , 576-585
Open AccessMulti‐Sequence Fusion MRI Deep Learning Models for Discrimination of Recurrent Nasopharyngeal Carcinoma and Osteoradionecrosis
Objectives: To develop a multi‐sequence fusion model based on MRI images to differentiate between recurrent nasopharyngeal carcinoma (rNPC) and osteoradionecrosis (ORN) in patients with nasopharyngeal carcinoma (NPC) after radiotherapy, and to evaluate its diagnostic performance. Methods: We retrospectively reviewed 370 patients with pathologically confirmed recurrent nasopharyngeal carcinoma (rNPC) or osteoradionecrosis (ORN). After screening, 346 patients (207 rNPC and 139 ORN) with both axial T1‐weighted contrast‐enhanced imaging (T1C) and T2‐weighted imaging (T2WI) were included and randomly split into a training set ( n = 212), validation set ( n = 61), and test set ( n = 73). A dual‐branch 3D‐ResNet‐50‐based fusion model was developed to integrate multi‐sequence MRI features. Model performance was evaluated using AUC, accuracy, sensitivity, specificity, precision, and F1 score. Results: On the test set, the proposed 3D‐ResNet‐Fusion model achieved an AUC of 0.86 and an accuracy of 84%, with a sensitivity of 91%, specificity of 72%, precision of 83%, and an F1 score of 0.87. Based on AUC comparisons, the fusion model outperformed comparator models based on EfficientNet (0.77, p = 0.20) and DenseNet (0.70, p = 0.02), as well as single‐sequence 3D‐ResNet models trained on T1C alone (0.71, p = 0.02) or T2WI alone (0.73, p = 0.046). In the human–AI comparison experiment, the proposed AI model achieved a 3% higher ACC than the senior otolaryngologist ( p = 0.83), and outperformed the two junior otolaryngologists by 15% ( p = 0.05) and 22% ( p < 0.01), respectively. Conclusion: The proposed AI model effectively integrates information from multiple MRI sequences, significantly improving classification performance in distinguishing rNPC from ORN.
- Open Access
- 29 July 2026
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (11) , 1309-1317
Tezepelumab in Chinese Patients With Severe Chronic Rhinosinusitis With Nasal Polyps: A Prespecified Subgroup Analysis of the Phase 3 WAYPOINT Trial
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) in Chinese patients often exhibits a mixed Type 1/2/3 inflammatory phenotype (63%), potentially impacting the efficacy of biologics targeting Type 2 inflammation. This prespecified subgroup analysis of WAYPOINT (NCT04851964) evaluated the efficacy and safety of tezepelumab in Chinese patients with CRSwNP. Methods: Adult patients with severe CRSwNP were randomized 1:1 to tezepelumab (210 mg) or placebo for 52 weeks. Co‐primary endpoints were changes from baseline at Week 52 (W52) in total nasal‐polyp score and bi‐weekly mean nasal‐congestion score. Key secondary endpoints included changes from baseline in Nasal Polyposis Symptom Diary (NPSD) loss‐of‐smell score, 22‐item Sinonasal Outcome Test (SNOT‐22) total score, Lund–Mackay score, NPSD total symptom score, and time to first nasal‐polyp surgery decision and/or systemic glucocorticoid use. Results: Twenty‐nine patients received tezepelumab, and 34 received placebo. At W52, tezepelumab achieved numerically greater improvements in total nasal‐polyp score (least‐squares mean difference vs. placebo [95% CI]: −2.03 [−2.88, −1.19]) and bi‐weekly mean nasal‐congestion score (−0.72 [−1.23, −0.21]). Compared with placebo, tezepelumab also improved NPSD loss‐of‐smell score (−0.44 [−0.82, −0.06]), SNOT‐22 total score (−16.34 [−29.80, −2.88]), Lund–Mackay score (−5.30 [−7.23, −3.38]), and NPSD total symptom score (−3.76 [−6.89, −0.63]). No tezepelumab‐treated patients required nasal‐polyp surgery or systemic glucocorticoids. Conclusion: Consistent with the overall population, tezepelumab reduced nasal‐polyp size and improved loss‐of‐smell and other sinonasal symptoms in Chinese patients with CRSwNP, with a favorable safety profile. No surgery or systemic glucocorticoids were required. These benefits were observed despite relatively lower baseline eosinophil counts in these patients. Further investigation is warranted to assess the generalizability to the broader Chinese population with CRSwNP.
- 29 July 2026
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (11) , 1309-1317
Open AccessTezepelumab in Chinese Patients With Severe Chronic Rhinosinusitis With Nasal Polyps: A Prespecified Subgroup Analysis of the Phase 3 WAYPOINT Trial
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) in Chinese patients often exhibits a mixed Type 1/2/3 inflammatory phenotype (63%), potentially impacting the efficacy of biologics targeting Type 2 inflammation. This prespecified subgroup analysis of WAYPOINT (NCT04851964) evaluated the efficacy and safety of tezepelumab in Chinese patients with CRSwNP. Methods: Adult patients with severe CRSwNP were randomized 1:1 to tezepelumab (210 mg) or placebo for 52 weeks. Co‐primary endpoints were changes from baseline at Week 52 (W52) in total nasal‐polyp score and bi‐weekly mean nasal‐congestion score. Key secondary endpoints included changes from baseline in Nasal Polyposis Symptom Diary (NPSD) loss‐of‐smell score, 22‐item Sinonasal Outcome Test (SNOT‐22) total score, Lund–Mackay score, NPSD total symptom score, and time to first nasal‐polyp surgery decision and/or systemic glucocorticoid use. Results: Twenty‐nine patients received tezepelumab, and 34 received placebo. At W52, tezepelumab achieved numerically greater improvements in total nasal‐polyp score (least‐squares mean difference vs. placebo [95% CI]: −2.03 [−2.88, −1.19]) and bi‐weekly mean nasal‐congestion score (−0.72 [−1.23, −0.21]). Compared with placebo, tezepelumab also improved NPSD loss‐of‐smell score (−0.44 [−0.82, −0.06]), SNOT‐22 total score (−16.34 [−29.80, −2.88]), Lund–Mackay score (−5.30 [−7.23, −3.38]), and NPSD total symptom score (−3.76 [−6.89, −0.63]). No tezepelumab‐treated patients required nasal‐polyp surgery or systemic glucocorticoids. Conclusion: Consistent with the overall population, tezepelumab reduced nasal‐polyp size and improved loss‐of‐smell and other sinonasal symptoms in Chinese patients with CRSwNP, with a favorable safety profile. No surgery or systemic glucocorticoids were required. These benefits were observed despite relatively lower baseline eosinophil counts in these patients. Further investigation is warranted to assess the generalizability to the broader Chinese population with CRSwNP.
- 19 March 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (7) , 833-835
Increased TRPV6 Potentiates Interleukin‐13 Signalling in Epithelial Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
Summary: TRPV6 is specifically elevated in nasal epithelial cells of eCRSwNP. Blockade of TRPV6 reduces epithelial type 2 inflammation.
- 19 March 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (7) , 833-835
Increased TRPV6 Potentiates Interleukin‐13 Signalling in Epithelial Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
Summary: TRPV6 is specifically elevated in nasal epithelial cells of eCRSwNP. Blockade of TRPV6 reduces epithelial type 2 inflammation.
- Open Access
- 7 January 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
Decreased Production of Tissue Plasminogen Activator in Endothelial Cells From Nasal Polyps
Introduction: Previous studies have demonstrated that chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by excessive fibrin deposition which is related to impaired production of tissue plasminogen activator(t‐PA) by epithelial cells. This study aims to evaluate whether t‐PA expression in endothelial cells is also decreased under the inflammatory milieu of CRSwNP. Methods: Vascularity and proangiogenic genes expression in polyp tissues from eosinophilic CRSwNP (eCRSwNP) and non‐eosinophilic CRSwNP (neCRSwNP) were assessed by immunohistochemistry and real‐time PCR. Single‐cell RNA sequencing data set of CRS, Immunohistochemistry were used. Human primary nasal endothelial cells were stimulated by IL‐13 and IFN‐γ with or without retinoic acid. Results: We observed the increased expression of proangiogenic genes and vascularity in both eCRSwNP and neCRSwNP. Single‐cell RNA sequencing and immunostaining revealed that t‐PA expression was decreased in endothelial cells of polyp tissues. In vitro study, IL‐13 and IFN‐γ could significantly attenuate t‐PA expression in endothelial cells, which can be rescued by retinoic acid. Conclusions: Our findings showed a significant contribution of endothelial cells in the production of t‐PA in sinonasal tissues. Furthermore, the levels of t‐PA in endothelial cells could also be impaired in the inflammatory environment of CRSwNP. Retinoic acid could restore t‐PA expression in endothelial cells impaired by inflammatory cytokines (including IL‐13 and IFN‐ γ), thus degrading the deposited fibrin in polyp tissue.
- 7 January 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
Open AccessDecreased Production of Tissue Plasminogen Activator in Endothelial Cells From Nasal Polyps
Introduction: Previous studies have demonstrated that chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by excessive fibrin deposition which is related to impaired production of tissue plasminogen activator(t‐PA) by epithelial cells. This study aims to evaluate whether t‐PA expression in endothelial cells is also decreased under the inflammatory milieu of CRSwNP. Methods: Vascularity and proangiogenic genes expression in polyp tissues from eosinophilic CRSwNP (eCRSwNP) and non‐eosinophilic CRSwNP (neCRSwNP) were assessed by immunohistochemistry and real‐time PCR. Single‐cell RNA sequencing data set of CRS, Immunohistochemistry were used. Human primary nasal endothelial cells were stimulated by IL‐13 and IFN‐γ with or without retinoic acid. Results: We observed the increased expression of proangiogenic genes and vascularity in both eCRSwNP and neCRSwNP. Single‐cell RNA sequencing and immunostaining revealed that t‐PA expression was decreased in endothelial cells of polyp tissues. In vitro study, IL‐13 and IFN‐γ could significantly attenuate t‐PA expression in endothelial cells, which can be rescued by retinoic acid. Conclusions: Our findings showed a significant contribution of endothelial cells in the production of t‐PA in sinonasal tissues. Furthermore, the levels of t‐PA in endothelial cells could also be impaired in the inflammatory environment of CRSwNP. Retinoic acid could restore t‐PA expression in endothelial cells impaired by inflammatory cytokines (including IL‐13 and IFN‐ γ), thus degrading the deposited fibrin in polyp tissue.
- Open Access
- 4 November 2025
- Published by Wiley in Clinical and Translational Allergy
- Vol. 15 (11) , e70119
Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) significantly impairs the quality of life, and disease control is now considered the primary treatment goal. Although patient‐reported outcome measures (PROMs) such as the 22‐item Sinonasal Outcome Test (SNOT‐22) and CRS‐PRO are widely used, their utility in predicting long‐term postoperative disease control remains limited. Methods: This prospective follow‐up study aimed to evaluate postoperative recovery and identify the predictors of suboptimal disease control in patients with CRSwNP by integrating preoperative PROMs with objective clinical features. A total of 102 patients with CRSwNP undergoing functional endoscopic sinus surgery (FESS) were enrolled, of whom 89 completed at least 12 months of follow‐up. Preoperative and postoperative PROMs were compared across disease control groups classified based on the European Position Paper on Rhinosinusitis and Nasal Polyps 2020 criteria. Least absolute shrinkage and selection operator regression was applied to select objective clinical predictors, which were then combined with either CRS‐PRO or SNOT‐22 item scores to develop and compare the nine machine learning models. Model performance was assessed using area under the curve (AUC), decision curve analysis, sensitivity, specificity, and other metrics. Results: Eosinophil and neutrophil counts were identified as key objective predictors of suboptimal disease control after FESS. Among all models, logistic regression incorporating CRS‐PRO scores and selected clinical features achieved the best performance, yielding an AUC of 0.866, accuracy of 83.3%, sensitivity of 72.7%, specificity of 89.5%, and F1‐score of 76.2%. This model demonstrated a strong discriminatory ability and potential utility in individualized clinical decision‐making. Conclusion: Integrating preoperative CRS‐PRO item scores with selected objective clinical parameters enables the accurate prediction of suboptimal disease control in patients with CRSwNP following FESS. This approach supports personalized risk stratification and postoperative management strategies.
- 4 November 2025
- Published by Wiley in Clinical and Translational Allergy
- Vol. 15 (11) , e70119
Open AccessPatient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) significantly impairs the quality of life, and disease control is now considered the primary treatment goal. Although patient‐reported outcome measures (PROMs) such as the 22‐item Sinonasal Outcome Test (SNOT‐22) and CRS‐PRO are widely used, their utility in predicting long‐term postoperative disease control remains limited. Methods: This prospective follow‐up study aimed to evaluate postoperative recovery and identify the predictors of suboptimal disease control in patients with CRSwNP by integrating preoperative PROMs with objective clinical features. A total of 102 patients with CRSwNP undergoing functional endoscopic sinus surgery (FESS) were enrolled, of whom 89 completed at least 12 months of follow‐up. Preoperative and postoperative PROMs were compared across disease control groups classified based on the European Position Paper on Rhinosinusitis and Nasal Polyps 2020 criteria. Least absolute shrinkage and selection operator regression was applied to select objective clinical predictors, which were then combined with either CRS‐PRO or SNOT‐22 item scores to develop and compare the nine machine learning models. Model performance was assessed using area under the curve (AUC), decision curve analysis, sensitivity, specificity, and other metrics. Results: Eosinophil and neutrophil counts were identified as key objective predictors of suboptimal disease control after FESS. Among all models, logistic regression incorporating CRS‐PRO scores and selected clinical features achieved the best performance, yielding an AUC of 0.866, accuracy of 83.3%, sensitivity of 72.7%, specificity of 89.5%, and F1‐score of 76.2%. This model demonstrated a strong discriminatory ability and potential utility in individualized clinical decision‐making. Conclusion: Integrating preoperative CRS‐PRO item scores with selected objective clinical parameters enables the accurate prediction of suboptimal disease control in patients with CRSwNP following FESS. This approach supports personalized risk stratification and postoperative management strategies.
- 18 September 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-17
Targeting IL-4/IL-13 Signaling Pathways in Chronic Rhinosinusitis with Nasal Polyps: From Mechanisms to Therapies
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common upper airway inflammatory disorder, characterized by persistent inflammation of the sinonasal mucosa and nasal polyp formation. The pivotal roles of interleukin (IL)-4/IL-13 signaling in CRSwNP pathogenesis is increasingly recognized, evidenced by the remarkable clinical success of biologics targeting this pathway. This review provides a concise overview of the IL-4/IL-13 pathway in CRSwNP, encompassing its molecular architecture, pathogenic mechanisms, current targeted therapies, and emerging therapeutic strategies.
- 18 September 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-17
Targeting IL-4/IL-13 Signaling Pathways in Chronic Rhinosinusitis with Nasal Polyps: From Mechanisms to Therapies
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common upper airway inflammatory disorder, characterized by persistent inflammation of the sinonasal mucosa and nasal polyp formation. The pivotal roles of interleukin (IL)-4/IL-13 signaling in CRSwNP pathogenesis is increasingly recognized, evidenced by the remarkable clinical success of biologics targeting this pathway. This review provides a concise overview of the IL-4/IL-13 pathway in CRSwNP, encompassing its molecular architecture, pathogenic mechanisms, current targeted therapies, and emerging therapeutic strategies.
- Open Access
- 20 June 2025
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (6) , 100869
Artificial intelligence-assisted detection of nasopharyngeal carcinoma on endoscopic images: a national, multicentre, model development and validation study
- 20 June 2025
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (6) , 100869
Open AccessArtificial intelligence-assisted detection of nasopharyngeal carcinoma on endoscopic images: a national, multicentre, model development and validation study
- Top Cited Papers
- 18 June 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-16
Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory condition characterized by persistent sinus inflammation and tissue remodeling. Epithelial-derived alarmins, including thymic stromal lymphopoietin (TSLP), interleukin-33 (IL-33), and interleukin-25 (IL-25), are critical mediators that initiate and amplify immune responses in CRSwNP. These alarmins are secreted by stressed or damaged nasal epithelial cells in response to environmental insults, such as allergens, microbial infections, pollutants, and proteases. Once released, they orchestrate immune cell activation and amplify inflammatory pathways. Targeting epithelial-derived alarmins has emerged as a promising therapeutic strategy for CRSwNP, with several biologics, including TSLP and IL-33 inhibitors, showing encouraging clinical outcomes. This review focuses on the role of epithelial-derived alarmins in CRSwNP, examining their expression patterns, regulatory mechanisms, and contributions to inflammation, evaluating the current progress in alarmin-targeted therapies, and exploring future research directions to optimize their clinical application. Graphical Abstract
- 18 June 2025
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 68 (1) , 1-16
Top Cited PapersCurrent Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory condition characterized by persistent sinus inflammation and tissue remodeling. Epithelial-derived alarmins, including thymic stromal lymphopoietin (TSLP), interleukin-33 (IL-33), and interleukin-25 (IL-25), are critical mediators that initiate and amplify immune responses in CRSwNP. These alarmins are secreted by stressed or damaged nasal epithelial cells in response to environmental insults, such as allergens, microbial infections, pollutants, and proteases. Once released, they orchestrate immune cell activation and amplify inflammatory pathways. Targeting epithelial-derived alarmins has emerged as a promising therapeutic strategy for CRSwNP, with several biologics, including TSLP and IL-33 inhibitors, showing encouraging clinical outcomes. This review focuses on the role of epithelial-derived alarmins in CRSwNP, examining their expression patterns, regulatory mechanisms, and contributions to inflammation, evaluating the current progress in alarmin-targeted therapies, and exploring future research directions to optimize their clinical application. Graphical Abstract
- 27 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (8) , 2748-2755
ICA Window: A Reliable Landmark for Locating Parapharyngeal ICA via Endoscopic Transoral Medial Pterygomandibular Fold Approach
Objective: One of the primary challenges in surgical procedures involving parapharyngeal space (PPS) lesions is accurately localizing the internal carotid artery (ICA) within the parapharyngeal space. This study aims to investigate the anatomical landmarks of the parapharyngeal internal carotid artery (ppICA) in endoscopic transoral approach surgery.Methods: A total of seven fresh frozen cadaveric heads (14 sides) were dissected using the endoscopic transoral medial pterygomandibular fold approach in the anatomical laboratory of the Surgical Treatment Technology Innovation Unit at Nasal Skull Base Tumor in Eye and ENT Hospital, Fudan University. Additionally, a comparative anatomical study was conducted on three cadaveric head specimens using the microscopic preauricular infratemporal approach. Photographic documentation and measurements were taken for adjacent structures of the ppICA, along with specific anatomical structures neighboring the ppICA. To illustrate the method for locating and protecting the ppICA, three cases involving the prestyloid, poststyloid, and retropharyngeal spaces were selected.Results: The stylopharyngeal muscle was located anterolaterally to the ppICA, while the levator veli palatini and longus capitis muscles were situated anterosuperiorly and posteromedially to the ppICA, respectively. The area enclosed by these three muscles was named the “ICA window” in this study. The ppICA was posterior to this window, sealed by the stylopharyngeal fascia. This ICA window was considered a reliable landmark for identification of the ppICA via endoscopic transoral medial pterygomandibular fold approach for PPS surgery.Conclusion: The ICA window, delineated by the stylopharyngeal muscle, tensor veli palatini muscle, longus capitis muscle, vaginal process of the tympanic bone, and the intervening fascial structures, emerges as a reliable anatomical landmark for orienting the ppICA during endoscopic transoral surgery for parapharyngeal space procedures.Level of Evidence: N/A
- 27 May 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (8) , 2748-2755
ICA Window: A Reliable Landmark for Locating Parapharyngeal ICA via Endoscopic Transoral Medial Pterygomandibular Fold Approach
Objective: One of the primary challenges in surgical procedures involving parapharyngeal space (PPS) lesions is accurately localizing the internal carotid artery (ICA) within the parapharyngeal space. This study aims to investigate the anatomical landmarks of the parapharyngeal internal carotid artery (ppICA) in endoscopic transoral approach surgery.Methods: A total of seven fresh frozen cadaveric heads (14 sides) were dissected using the endoscopic transoral medial pterygomandibular fold approach in the anatomical laboratory of the Surgical Treatment Technology Innovation Unit at Nasal Skull Base Tumor in Eye and ENT Hospital, Fudan University. Additionally, a comparative anatomical study was conducted on three cadaveric head specimens using the microscopic preauricular infratemporal approach. Photographic documentation and measurements were taken for adjacent structures of the ppICA, along with specific anatomical structures neighboring the ppICA. To illustrate the method for locating and protecting the ppICA, three cases involving the prestyloid, poststyloid, and retropharyngeal spaces were selected.Results: The stylopharyngeal muscle was located anterolaterally to the ppICA, while the levator veli palatini and longus capitis muscles were situated anterosuperiorly and posteromedially to the ppICA, respectively. The area enclosed by these three muscles was named the “ICA window” in this study. The ppICA was posterior to this window, sealed by the stylopharyngeal fascia. This ICA window was considered a reliable landmark for identification of the ppICA via endoscopic transoral medial pterygomandibular fold approach for PPS surgery.Conclusion: The ICA window, delineated by the stylopharyngeal muscle, tensor veli palatini muscle, longus capitis muscle, vaginal process of the tympanic bone, and the intervening fascial structures, emerges as a reliable anatomical landmark for orienting the ppICA during endoscopic transoral surgery for parapharyngeal space procedures.Level of Evidence: N/A
- 21 March 2025
- Published by Wiley in Head & Neck
- Vol. 47 (8)
EC–IC Bypass for Skull Base Necrosis and ICA Rupture Hemorrhage After Radiotherapy for Nasopharyngeal Carcinoma
Background: Skull base necrosis can cause life‐threatening massive bleeding in patients following radiotherapy and chemotherapy for nasopharyngeal carcinoma. Patients with bilateral internal carotid artery rupture and hemorrhage are especially susceptible, which is a major challenge for clinicians.Methods: A team at the Eye and ENT Hospital affiliated with Fudan University recently successfully treated a patient with skull base necrosis after radiotherapy and chemotherapy for nasopharyngeal carcinoma. The patient experienced bilateral internal carotid artery rupture with massive nasopharyngeal hemorrhage and was treated with extracranial–intracranial bypass surgery, resection of the nasal skull base necrotic lesions, and bilateral internal carotid artery occlusion.Results: One week after the last surgery, the patient recovered well, and normal activity was restored.Conclusions: Simultaneous EC–IC bypass and TMF repair increase intracranial blood flow compensation without the need for an additional incision, saving the patient's life and improving their quality of life. These results highlight a promising surgical practice for rescuing patients suffering from skull base necrosis and ICA rupture hemorrhage.
- 21 March 2025
- Published by Wiley in Head & Neck
- Vol. 47 (8)
EC–IC Bypass for Skull Base Necrosis and ICA Rupture Hemorrhage After Radiotherapy for Nasopharyngeal Carcinoma
Background: Skull base necrosis can cause life‐threatening massive bleeding in patients following radiotherapy and chemotherapy for nasopharyngeal carcinoma. Patients with bilateral internal carotid artery rupture and hemorrhage are especially susceptible, which is a major challenge for clinicians.Methods: A team at the Eye and ENT Hospital affiliated with Fudan University recently successfully treated a patient with skull base necrosis after radiotherapy and chemotherapy for nasopharyngeal carcinoma. The patient experienced bilateral internal carotid artery rupture with massive nasopharyngeal hemorrhage and was treated with extracranial–intracranial bypass surgery, resection of the nasal skull base necrotic lesions, and bilateral internal carotid artery occlusion.Results: One week after the last surgery, the patient recovered well, and normal activity was restored.Conclusions: Simultaneous EC–IC bypass and TMF repair increase intracranial blood flow compensation without the need for an additional incision, saving the patient's life and improving their quality of life. These results highlight a promising surgical practice for rescuing patients suffering from skull base necrosis and ICA rupture hemorrhage.